Zhu Yimiao, Tu Jiangfeng, Zhao Yu, Jing Jiyong, Dong Zhiyuan, Pan Wensheng
Department of Gastroenterology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.
Department of Endocrinology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China.
Int J Gen Med. 2021 Jun 28;14:2953-2963. doi: 10.2147/IJGM.S315306. eCollection 2021.
The guidelines recommend urgent biliary drainage (BD) for severe acute cholangitis, without a clear definition of "urgent". To explore the optimal time, we identified the impact of timing of BD on clinical outcomes in severe acute cholangitis.
A retrospective study of patients with severe acute cholangitis was conducted based on the Multiparameter Intelligent Monitoring in Intensive Care III (MIMIC-III) database. Multivariable regressions were used to identified the effect of timing of BD on in-hospital mortality, 30-day mortality, and the length of stay (LOS) in hospital and the intensive care unit (ICU) with adjustment for confounding factors.
A total of 106 severe acute cholangitis patients underwent BD with a median time of 14.14 hours (IQR: 7.60-32.59). Among them, 67.9% were performed within 24 hours and 80.2% within 48 hours. Median length of stay was 2.65 days (IQR: 1.70-5.12) in the ICU and 7.54 days (IQR: 4.49-17.17) in hospital. The in-hospital and 30-day mortality rates were 13.2% and 14.2%, respectively. On multivariate analysis, every 1-day delay of BD increased 1.49 days of stay in hospital (P<0.0001). Delayed BD (>48 hours) was linked with 5.56 days longer ICU LOS (P = 0.0096), while urgent BD (<24 hours) did not significantly shorten the ICU stay (P = 0.0997). No significant increase was observed on in-hospital mortality (OR = 1.03; 95% CI 0.93-1.13) nor 30-day mortality (OR=1.01; 95% CI 0.87-1.14) with BD delay in this population.
In severe acute cholangitis patients, delay in BD increased in-hospital LOS. BD after 48 hours was associated with longer ICU LOS. Yet, BD within 24 hours did not significantly reduce the mortality nor shortened the ICU LOS.
指南推荐对重症急性胆管炎进行紧急胆道引流(BD),但未对“紧急”给出明确定义。为探究最佳时机,我们确定了BD时机对重症急性胆管炎临床结局的影响。
基于重症监护多参数智能监测三期(MIMIC-III)数据库对重症急性胆管炎患者进行回顾性研究。采用多变量回归分析确定BD时机对住院死亡率、30天死亡率以及住院时间和重症监护病房(ICU)住院时间的影响,并对混杂因素进行校正。
共有106例重症急性胆管炎患者接受了BD,中位时间为14.14小时(四分位间距:7.60 - 32.59)。其中,67.9%在24小时内进行,80.2%在48小时内进行。ICU中位住院时间为2.65天(四分位间距:1.70 - 5.12),住院中位时间为7.54天(四分位间距:4.49 - 17.17)。住院死亡率和30天死亡率分别为13.2%和14.2%。多变量分析显示,BD每延迟1天,住院时间增加1.49天(P<0.0001)。延迟BD(>48小时)与ICU住院时间延长5.56天相关(P = 0.0096),而紧急BD(<24小时)并未显著缩短ICU住院时间(P = 0.0997)。在该人群中,BD延迟并未使住院死亡率(OR = 1.03;95%置信区间0.93 - 1.13)和30天死亡率(OR = 1.01;95%置信区间0.87 - 1.14)显著增加。
在重症急性胆管炎患者中,BD延迟会增加住院时间。48小时后进行BD与ICU住院时间延长相关。然而,24小时内进行BD并未显著降低死亡率,也未缩短ICU住院时间。